Use of xenofree matrices and molecularly-defined media to control human embryonic stem cell pluripotency: Effect of low physiological TGF-β concentrations

Stem Cells and Development

Volumn 17, Issue 3, 2008, Pages 519-533

  Peiffer, Isabelle ^a,b   Barbet, Romain ^a   Zhou, Yi Ping ^a,c   Li, Ma Lin ^a,c   Monier, Marie Noëlle ^a   Hatzfeld, Antoinette ^a   Hatzfeld, Jacques A ^a  

^a CNRS   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL RENEWAL; CELL STRUCTURE; CERBERUS 1 GENE; CONTROLLED STUDY; CULTURE MEDIUM; CYSTINE KNOT MOTIF; DOWN REGULATION; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; GENE; GENE EXPRESSION; GREMLIN 1 GENE; HUMAN; HUMAN CELL; KARYOTYPE; LEFTY1 GENE; LEFTY2 GENE; MESENCHYMAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS; UPREGULATION;

ACTIVINS; ALBUMINS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CULTURE MEDIA; CYTOKINES; DOWN-REGULATION; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KARYOTYPING; MICE; PHENOTYPE; PLURIPOTENT STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

IPS; MURINAE;

EID: 46749118841     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0279     Document Type: Article

References (66)

1. Laslett AL, S Grimmond, B Gardiner, L Stamp, A Lin, SM Hawes, S Wormald, D Nikolic-Paterson, D Haylock and MF Pera. (2007). Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev Biol 7:12.
2. Li SS, YH Liu, CN Tseng, TL Chung, TY Lee and S Singh. (2006). Characterization and gene expression profiling of five new human embryonic stem cell lines derived in Taiwan. Stem Cells Dev 15:532-555.
3. Skottman H, M Mikkola, K Lundin, C Olsson, AM Stromberg, T Tuuri, T Otonkoski, O Hovatta and R Lahesmaa. (2005). Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 23:1343-1356.
4. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
5. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
6. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, Slukvin, II and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
7. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
8. Mallon BS, KY Park, KG Chen, RS Hamilton and RD McKay. (2006). Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol 38:1063-1075.
9. Rajala K, H Hakala, S Panula, S Aivio, H Pihlajamaki, R Suuronen, O Hovatta and H Skottman. (2007). Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod 22:1231-1238.
10. Amit M, V Margulets, H Segev, K Shariki, I Laevsky, R Coleman and J Itskovitz-Eldor. (2003). Human feeder layers for human embryonic stem cells. Biol Reprod 68:2150-2156.
11. Cheng L, H Hammond, Z Ye, X Zhan and G Dravid. (2003). Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 21:131-142.
12. Ellerstrom C, R Strehl, K Moya, K Andersson, C Bergh, K Lundin, J Hyllner and H Semb. (2006). Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24:2170-2176.
13. Genbacev O, A Krtolica, T Zdravkovic, E Brunette, S Powell, A Nath, E Caceres, M McMaster, S McDonagh, Y Li, R Mandalam, J Lebkowski and SJ Fisher. (2005). Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril 83:1517-1529.
14. Hovatta O, M Mikkola, K Gertow, AM Stromberg, J Inzunza, J Hreinsson, B Rozell, E Blennow, M Andang and L Ahrlund-Richter. (2003). A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 18:1404-1409.
15. Inzunza J, K Gertow, MA Stromberg, E Matilainen, E Blennow, H Skottman, S Wolbank, L Ahrlund-Richter and O Hovatta. (2005). Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23:544-549.
16. Koivisto H, M Hyvarinen, AM Stromberg, J Inzunza, E Matilainen, M Mikkola, O Hovatta and H Teerijoki. (2004). Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reprod Biomed Online 9:330-337.
17. Lee JB, JE Lee, JH Park, SJ Kim, MK Kim, SI Roh and HS Yoon. (2005). Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod 72:42-49.
18. Richards M, CY Fong, WK Chan, PC Wong and A Bongso. (2002). Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 20:933-936.
19. Stojkovic P, M Lako, S Przyborski, R Stewart, L Armstrong, J Evans, X Zhang and M Stojkovic. (2005). Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 23:895-902.
20. Yoo SJ, BS Yoon, JM Kim, JM Song, SI Roh, S You and HS Yoon. (2005). Efficient culture system for human embryonic stem cells using autologous human embryonic stem cell-derived feeder cells. Exp Mol Med 37:399-407.
21. Kleinman HK, ML McGarvey, LA Liotta, PG Robey, K Tryggvason and GR Martin. (1982). Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188-6193.
22. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold and MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971-974.
23. Amit M and J Itskovitz-Eldor. (2006). Maintenance of human embryonic stem cells in animal serum- and feeder layer-free culture conditions. Methods Mol Biol 331:105-113.
24. Amit M, C Shariki, V Margulets and J Itskovitz-Eldor. (2004). Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70:837-845.
25. Beattie GM, AD Lopez, N Bucay, A Hinton, MT Firpo, CC King and A Hayek. (2005). Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23:489-495.
26. Liu Y, Z Song, Y Zhao, H Qin, J Cai, H Zhang, T Yu, S Jiang, G Wang, M Ding and H Deng. (2006). A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun 346:131-139.
27. Ludwig TE, ME Levenstein, JM Jones, WT Berggren, ER Mitchen, JL Frane, LJ Crandall, CA Daigh, KR Conard, MS Piekarczyk, RA Llanas and JA Thomson. (2006). Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185-187.
28. Li Y, S Powell, E Brunette, J Lebkowski and R Mandalam. (2005). Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91:688-698.
29. Lu J, R Hou, CJ Booth, SH Yang and M Snyder. (2006). Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci USA 103:5688-5693.
30. Vallier L, M Alexander and RA Pedersen. (2005). Activin/nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118:4495-4509.
31. Vallier L, D Reynolds and RA Pedersen. (2004). Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 275:403-421.
32. Yao S, S Chen, J Clark, E Hao, GM Beattie, A Hayek and S Ding. (2006). Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 103:6907-6912.
33. Curry S. (2002). Beyond expansion: structural studies on the transport roles of human serum albumin. Vox Sang 83 Suppl 1:315-319.
34. Barnes D and GH Sato. (1980). Methods for growth of cultured cells in serum-free medium. Anal Biochem 102:255-270.
35. Wolfe RA, R Wu and GH Sato. (1980). Epidermal growth factor-induced down-regulation of receptor does not occur in HeLa cells grown in defined medium. Proc Natl Acad Sci USA 77:2735-2739.
36. Hatzfeld JA, A Hatzfeld and J Maigne. (1982). Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. Proc Natl Acad Sci USA 79:6280-6284.
37. Zhou YQ, JP Levesque, A Hatzfeld, AA Cardoso, ML Li, P Sansilvestri and J Hatzfeld. (1993). Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors. Blood 82:800-806.
38. Fortunel NO, A Hatzfeld and JA Hatzfeld. (2000). Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 96:2022-2036.
39. Batard P, MN Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld and JA Hatzfeld. (2000). TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 113 (Pt 3):383-390.
40. Fortunel N, J Hatzfeld, L Aoustin, P Batard, K Ducos, MN Monier, A Charpentier and A Hatzfeld. (2000). Specific dose-response effects of TGF-beta1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood. Hematol J 1:126-135.
41. Fortunel NO, JA Hatzfeld, PA Rosemary, C Ferraris, MN Monier, V Haydont, J Longuet, B Brethon, B Lim, I Castiel, R Schmidt and A Hatzfeld. (2003). Long-term expansion of human functional epidermal precursor cells: promotion of extensive amplification by low TGF-beta1 concentrations. J Cell Sci 116:4043-4052.
42. Chen S, A Choo, A Chin and SK Oh. (2006). TGF-beta2 allows pluripotent human embryonic stem cell proliferation on E6/E7 immortalized mouse embryonic fibroblasts. J Biotechnol 122:341-361.
43. Greber B, H Lehrach and J Adjaye. (2007). Fibroblast growth factor 2 modulates transforming growth factor β signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells 25:455-464.
44. James D, AJ Levine, D Besser and A Hemmati-Brivanlou. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132:1273-1282.
45. Poon E, F Clermont, MT Firpo and RJ Akhurst. (2006). TGFβ inhibition of yolk-sac-like differentiation of human embryonic stem-cell-derived embryoid bodies illustrates differences between early mouse and human development. J Cell Sci 119:759-768.
46. Schuldiner M, O Yanuka, J Itskovitz-Eldor, DA Melton and N Benvenisty. (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97:11307-11312.
47. Wang G, H Zhang, Y Zhao, J Li, J Cai, P Wang, S Meng, J Feng, C Miao, M Ding, D Li and H Deng. (2005). Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 330:934-942.
48. Xiao L, X Yuan and SJ Sharkis. (2006). Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24:1476-1486.
49. Massague J, J Seoane and D Wotton. (2005). Smad transcription factors. Genes Dev 19:2783-2810.
50. Valdimarsdottir G and C Mummery. (2005). Functions of the TGFbeta superfamily in human embryonic stem cells. Apmis 113:773-789.
51. Hsu DR, AN Economides, X Wang, PM Eimon and RM Harland. (1998). The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1:673-683.
52. Kueh J, M Richards, SW Ng, WK Chan and A Bongso. (2006). The search for factors in human feeders that support the derivation and propagation of human embryonic stem cells: preliminary studies using transcriptome profiling by serial analysis of gene expression. Fertil Steril 85:1843-1846.
53. Sun J, FF Zhuang, JE Mullersman, H Chen, EJ Robertson, D Warburton, YH Liu and W Shi. (2006). BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction. J Biol Chem 281:29349-29356.
54. Katoh M and M Katoh. (2006). CER1 is a common target of WNT and NODAL signaling pathways in human embryonic stem cells. Int J Mol Med 17:795-799.
55. Peiffer I, D Belhomme, R Barbet, V Haydont, YP Zhou, NO Fortunel, M Li, A Hatzfeld, JN Fabiani and JA Hatzfeld. (2007). Simultaneous differentiation of endothelial and trophoblastic cells derived from human embryonic stem cells. Stem Cells Dev 16:393-402.
56. Peiffer I, P Eid, R Barbet, ML Li, RA Oostendorp, V Haydont, MN Monier, L Milon, N Fortunel, P Charbord, M Tovey, J Hatzfeld and A Hatzfeld. (2007). A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon alpha/beta. Leukemia 21:714-724.
57. Peiffer I, AB Blanc-Potard, MF Bernet-Camard, J Guignot, A Barbat and AL Servin. (2000). Afa/Dr diffusely adhering Escherichia coli C1845 infection promotes selective injuries in the junctional domain of polarized human intestinal Caco-2/TC7 cells. Infect Immun 68:3431-3442.
58. Sirven A, E Ravet, P Charneau, V Zennou, L Coulombel, D Guetard, F Pflumio and A Dubart-Kupperschmitt. (2001). Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 3:438-448.
59. Pick M, L Azzola, A Mossman, EG Stanley and AG Elefanty. (2007). Differentiation of human embryonic stem cells in serum free medium reveals distinct roles for BMP4, VEGF, SCF and FGF2 in hematopoiesis. Stem Cells 25:2206-2214.
60. Spradling A, D Drummond-Barbosa and T Kai. (2001). Stem cells find their niche. Nature 414:98-104.
61. Draper JS, K Smith, P Gokhale, HD Moore, E Maltby, J Johnson, L Meisner, TP Zwaka, JA Thomson and PW Andrews. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22:53-54.
62. Sneddon JB, HH Zhen, K Montgomery, M van de Rijn, AD Tward, R West, H Gladstone, HY Chang, GS Morganroth, AE Oro and PO Brown. (2006). Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA 103:14842-14847.
63. Prowse AB, LR McQuade, KJ Bryant, H Marcal and PP Gray. (2007). Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media. J Proteome Res 6:3796-3807.
64. Prowse AB, LR McQuade, KJ Bryant, DD Van Dyk, BE Tuch and PP Gray. (2005). A proteome analysis of conditioned media from human neonatal fibroblasts used in the maintenance of human embryonic stem cells. Proteomics 5:978-989.
65. Hatzfeld J, ML Li, EL Brown, H Sookdeo, JP Levesque, T O'Toole, C Gurney, SC Clark and A Hatzfeld. (1991). Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med 174:925-929.
66. Namkoong H, SM Shin, HK Kim, SA Ha, GW Cho, SY Hur, TE Kim and JW Kim. (2006). The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6:74.